Bonus BioGroup Ltd. (TLV:BONS)

Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
19.00
+0.50 (2.70%)
May 7, 2025, 5:24 PM IDT
14.46%
Market Cap 216.07M
Revenue (ttm) n/a
Net Income (ttm) -27.83M
Shares Out 1.17B
EPS (ttm) -0.02
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 819,407
Average Volume 1,008,020
Open 18.50
Previous Close 18.50
Day's Range 18.50 - 19.10
52-Week Range 9.00 - 22.80
Beta 0.76
RSI 64.45
Earnings Date May 29, 2025

About Bonus BioGroup

Bonus BioGroup Ltd., a clinical-stage biotechnology company, develops products based on tissue engineering and cell therapy. The company’s products in development include BonoFill for bone tissue regeneration in maxillofacial and orthopedic indications and is in Phase II clinical trial; and MesenCure for the treatment of COVID patients suffering from pneumonia and ARDS and is in phase III trial. Its products in pipeline also comprise BonoFill for bone augmentation in osteoporosis patients; MesenCure for treating other inflammations and tissue d... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1981
Employees 49
Stock Exchange Tel Aviv Stock Exchange
Ticker Symbol BONS
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.